Close X
Attorney Spotlight

How does Jordana Nelson's prior experience as a general counsel inform her work with firm clients? Read more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

The M&A Advisor Winner 2017The M&A Advisor announced the winners of the 16th Annual M&A Advisor Awards on Monday, November 13 at the 2017 M&A Advisor Awards. Bass, Berry & Sims was named a winner in the two categories related to the following deals:

M&A Deal of the Year (from $1B-$5B) – Acquisition of CLARCOR Inc. by Parker Hannifin Corporation

Corporate/Strategic Deal of the Year (over $1B) – Acquisition of BNC Bancorp by Pinnacle Financial Partners

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Regulation A+

It seems that lately there has been a noticeable uptick in Regulation A+ activity, including several recent Reg A+ securities offerings where the stock now successfully trades on national exchanges. In light of this activity, we have published a set of FAQs about Regulation A+ securities offerings to help companies better understand this "mini-IPO" offering process, as well as pros and cons compared to a traditional underwritten IPO.

Read now

AmSurg Corp Merges with Envision Healthcare

Client Type: Public Company

We represented AmSurg Corp. (NASDAQ: AMSG) in its merger with Envision Healthcare Holdings, Inc. The combination of Envision Healthcare and AMSURG brings together two leading, complementary healthcare companies to form one of the nation’s largest provider organizations. 

Envision Healthcare Corporation is co-headquartered in Nashville, Tennessee, and Greenwood Village, Colorado. The company’s common stock will begin trading on the New York Stock Exchange tomorrow, December 2, 2016, under the ticker symbol EVHC and will become part of the S&P 500 stock index.

The new Envision is the leading provider of physician-led services, ambulatory surgery center management, post-acute care and medical transportation. The company manages a highly differentiated suite of clinical solutions to support health systems, communities and payors, is composed of a significantly diversified business mix of specialties, customers and geographies, and provides a broader continuum of patient care.

Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Additional details about the definitive merger agreement can be found in the official news release posted on Envision's website.

Award iconThis transaction was one of six separate deals involving Bass, Berry & Sims that was recognized as a Finalist for the 16th Annual M&A Advisor Awards in the categories of 

    • M&A Deal of the Year (over $5B)
    • Corporate/Strategic Deal of the Year (over $1B) 
    • Healthcare and Life Sciences Deal of the Year (over $100MM)

You Also May Be Interested In:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.